BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 10.47 thousand shares for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-13.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-04-13
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-02-28 was 938.00 shares, a 99.56% decline year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-11-30 was 8.81K shares, a 90.37% decline year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-08-31 was 720.00 shares, a 99.70% decline year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-02-28 was 213.75K shares, a 1235.94% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2026-02-28 | 938.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | 9.75K shares derived: sum of 2 quarters · filed 2026-04-13 | 10.47K shares 10-Q · filed 2026-04-13 |
| 2025-11-30 | 8.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | 9.53K shares 10-Q · filed 2026-01-14 | |
| 2025-08-31 | 720.00 shares 10-Q · filed 2025-10-14 | ||
| 2025-02-28 | 213.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-14 | 305.25K shares derived: sum of 2 quarters · filed 2025-04-14 | 545.75K shares 10-Q · filed 2025-04-14 |
| 2024-11-30 | 91.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-14 | 332.00K shares 10-Q · filed 2025-01-14 | |
| 2024-08-31 | 240.50K shares 10-Q · filed 2024-10-15 | ||
| 2024-02-29 | 16.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-12 | 117.00K shares derived: sum of 2 quarters · filed 2024-04-12 | 164.50K shares 10-Q · filed 2024-04-12 |
| 2023-11-30 | 101.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | 148.50K shares 10-Q · filed 2024-01-16 | |
| 2023-08-31 | 47.50K shares 10-Q · filed 2023-10-12 | ||
| 2018-08-31 | 3.50K shares 10-Q · filed 2018-10-15 | ||
| 2017-08-31 | 3.00K shares 10-Q · filed 2017-10-16 | ||
| 2016-08-31 | 5.00K shares 10-Q · filed 2016-10-17 | ||
| 2015-08-31 | 20.38K shares 10-Q · filed 2015-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |